Biomerica (BMRA): Utang-utang marang kapitalisasi buku

Tandha merek Biomerica Inc. (BMRA)

Severe pricing pressure in diagnostics and a reliance on clinic discounts are squeezing the margins of Biomerica, Inc. (BMRA). An assessment of the debt-to-book capitalization ratio visualizes the impact of this policy, where the value of 0.60 corresponds to the current metric. Efficient warehouse automation and test-kit logistics support profitability, while the implementation of eco-packaging and waste disposal minimize environmental risks.

BMRA Rasio utang marang nilai buku Biomerica Inc (04.07.2022 - 28.10.2026)
Produk asli Biomerica Inc

Assessing the stability of the financing structure is critical for capital protection during periods of uncertainty. This indicator measures the proportion of debt relative to equity, determining the level of financial risk. By analyzing the total debt-to-equity chart, an investor can see the balance between safety and expansion rates. For Biomerica, Inc. (BMRA), this parameter determines the ability to scale sales of high-margin EZ Detect tests without excessive credit leverage. Optimizing this ratio ensures the stable development of the diagnostics business.

Pesaing Biomerica, Inc.

A - Utang-utang marang kapitalisasi buku|Rasio utang marang nilai buku questdiagnostics.com DGX|Illumina - Utang-utang marang kapitalisasi buku|EXAS: Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku PerkinElmer|Bio-Rad Corp (BIO) - Rasio utang marang nilai buku|NNNN (Anbio Biotechnology) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku SHC|Rasio utang marang kapitalisasi buku QuidelOrtho Corporation (QDEL)|Rasio utang marang kapitalisasi buku OPKO Health Inc OPK|CDNA: Utang marang nilai buku|Maravai - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku FLGT (Fulgent Genetics, Inc.)|LAB - Utang-utang marang aset resik|Cytek Biosciences - Utang-utang marang kapitalisasi buku|OSUR (OraSure Technologies, Inc.) - Utang-utang marang aset resik|XGN: Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik MDxHealth, Inc.|Utang-utang marang kapitalisasi buku Lucid Diagnostics Inc. (LUCD)|Rasio utang marang kapitalisasi buku prenetics.com (PRE)|Utang-utang marang kapitalisasi buku IMDX|Trinity Biotech PLC - Utang-utang marang aset resik|PRPH (ProPhase) - Rasio utang marang kapitalisasi buku|AIMD: Utang-utang marang nilai buku|CODX (Co-Diagnostics, Inc.) - Rasio utang marang kapitalisasi buku|heartsciences.com (HSCS) - Utang marang nilai buku|Utang-utang marang kapitalisasi buku CDIO (Cardio Diagnostics Holdings Inc.)|Utang-utang marang nilai buku VRAX|Bluejay (BJDX) - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik Aspira Women's Health Inc (AWH)|Utang-utang marang kapitalisasi buku AXDX|Utang-utang marang aset resik centogene.com CNTG|ENZ: Utang-utang marang kapitalisasi buku|FRES - Utang marang nilai buku|GENE: Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku 23andMe Inc|PMD - Utang marang nilai buku